Market Insights Consumer OTC Pharmaceuticals

Wound Care - China

China

Revenue in the Wound Care market amounts to €198.00 in 2024. The market is expected to grow annually by 0.93% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€975 in 2024).
In relation to total population figures, per person revenues of €0.14 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Wound Care market in China is experiencing significant growth and development.

Customer preferences: Chinese consumers are increasingly seeking high-quality wound care products that can effectively treat various types of wounds. They prioritize products that are safe, easy to use, and provide quick relief. Additionally, with the growing awareness of the importance of wound care and the increasing aging population in China, there is a rising demand for advanced wound care products that promote faster healing and reduce the risk of infection.

Trends in the market: One major trend in the Chinese Wound Care market is the increasing adoption of advanced wound care products. Traditional wound care products, such as adhesive bandages and gauze dressings, are being replaced by innovative products like foam dressings, hydrogels, and alginate dressings. These advanced products offer better wound management, moisture control, and enhanced healing properties. Another trend is the growing popularity of wound care products with antimicrobial properties. Chinese consumers are becoming more concerned about the risk of infection associated with wounds, and they are actively seeking products that can prevent or reduce the risk of infection. As a result, wound care products with antimicrobial agents, such as silver or iodine, are in high demand.

Local special circumstances: China has a large and rapidly aging population, which contributes to the increasing demand for wound care products. As people age, their skin becomes more fragile and prone to wounds, such as pressure ulcers and diabetic foot ulcers. This demographic trend is driving the growth of the wound care market in China. Additionally, China has a high prevalence of chronic diseases, such as diabetes and cardiovascular diseases, which often lead to chronic wounds. The management of chronic wounds requires specialized wound care products and treatments, further fueling the demand for wound care products in the country.

Underlying macroeconomic factors: China's healthcare system has undergone significant improvements in recent years, with increased government spending on healthcare infrastructure and reforms aimed at providing better access to healthcare services. This has resulted in improved healthcare facilities and increased availability of wound care products across the country. Furthermore, the rising disposable income of Chinese consumers has enabled them to afford higher-quality wound care products. As a result, the market for premium wound care products is growing, as consumers are willing to pay more for products that offer superior performance and comfort. In conclusion, the Wound Care market in China is witnessing growth and development driven by customer preferences for high-quality and advanced wound care products, the increasing adoption of advanced wound care products and products with antimicrobial properties, the demographic trend of an aging population, the high prevalence of chronic diseases, improvements in the healthcare system, and the rising disposable income of Chinese consumers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.